Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a loss of -5.47%.However, over the last six months, we can see a stronger performance of -39.50%. Over the last 30 days, the price of CRDL has leaped by -9.02%. And in the last five days, it has fallen by -5.47%.
Cardiol Therapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $3.12 on 06/12/24, while the lowest price for the same period was registered at $0.96 on 02/12/24.
52-week price history of CRDL Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Cardiol Therapeutics Inc’s current trading price is -61.22% away from its 52-week high, while its distance from the 52-week low is 26.11%. The stock’s price range during this period has varied between$0.96 and $3.12. The Cardiol Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.21 million for the day, a figure considerably lower than their average daily volume of 0.37 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Cardiol Therapeutics Inc (CRDL) has experienced a quarterly decline of -36.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 98.74M and boasts a workforce of 22 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.7474, with a change in price of -0.7700. Similarly, Cardiol Therapeutics Inc recorded 429,893 in trading volume during the last 100 days, posting a change of -38.89%.
CRDL’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CRDL stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.
CRDL Stock Stochastic Average
Cardiol Therapeutics Inc’s raw stochastic average for the past 50 days is presently 3.74%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 11.76%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 10.58% and 11.85%, respectively.
